Large-scale testing (Phase 3)WithdrawnNCT01893242
What this trial is testing
Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)
Who this might be right for
Diabetes Mellitus Type 2, Kidney Disease, Chronic
Hoffmann-La Roche